We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
-12.95%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$51.8B
AUM Growth
-$9.63B
Cap. Flow
-$699M
Cap. Flow %
-1.35%
Top 10 Hldgs %
15.72%
Holding
2,464
New
302
Increased
769
Reduced
979
Closed
219

Top Sells

Rank Stock Value
1
ESRX
Express Scripts Holding Company
ESRX
+$792M
2
CA
CA, Inc.
CA
+$718M
3
V icon
Visa
V
+$129M
4
MA icon
Mastercard
MA
+$103M
5
EA icon
Electronic Arts
EA
+$98.7M

Sector Composition

Rank Sector Weight
1 Healthcare 18.67%
2 Financials 15.84%
3 Technology 11.21%
4 Industrials 8.66%
5 Energy 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLO icon
801
Allogene Therapeutics
ALLO
$601M
$3.95M 0.01%
+146,779
New +$3.9M
GLD icon
802
SPDR Gold Trust
GLD
$131B
$3.94M 0.01%
32,474
-346
-1% -$40.2K
FRT icon
803
Federal Realty Investment Trust
FRT
$10.9B
$3.93M 0.01%
33,325
-2,000
-6% -$251K
MYGN icon
804
Myriad Genetics
MYGN
$530M
$3.92M 0.01%
135,000
-200
-0.1% -$7.2K
SRCI
805
DELISTED
SRC Energy Inc
SRCI
$3.92M 0.01%
834,231
-3,599,831
-81% -$24.1M
CNI icon
806
Canadian National Railway
CNI
$78.3B
$3.91M 0.01%
52,766
+420
+0.8% +$34.8K
CHRS icon
807
Coherus Oncology
CHRS
$217M
$3.9M 0.01%
430,300
INCY icon
808
Incyte
INCY
$23.5B
$3.83M 0.01%
60,300
-100
-0.2% -$6.49K
IT icon
809
Gartner
IT
$9.41B
$3.81M 0.01%
29,843
-6,938
-19% -$1M
EXP icon
810
Eagle Materials
EXP
$6.6B
$3.75M 0.01%
61,534
+8,325
+16% +$597K
SNP
811
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
$3.73M 0.01%
52,794
-400
-0.8% -$33.4K
RIO icon
812
Rio Tinto
RIO
$148B
$3.72M 0.01%
76,816
GLPI icon
813
Gaming and Leisure Properties
GLPI
$12.8B
$3.71M 0.01%
115,000
+27,500
+31% +$931K
AWK icon
814
American Water Works
AWK
$26.3B
$3.7M 0.01%
40,800
-20,000
-33% -$1.83M
ICPT
815
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$3.68M 0.01%
36,527
+966
+3% +$100K
RIGL icon
816
Rigel Pharmaceuticals
RIGL
$680M
$3.68M 0.01%
160,000
HOMB icon
817
Home BancShares
HOMB
$6.21B
$3.67M 0.01%
224,455
CLLS
818
Cellectis
CLLS
$286M
$3.66M 0.01%
219,675
+28,688
+15% +$665K
IRBT
819
DELISTED
iRobot
IRBT
$3.65M 0.01%
43,640
+24,740
+131% +$2.24M
BNS icon
820
Scotiabank
BNS
$106B
$3.64M 0.01%
73,100
+48,780
+201% +$2.63M
ROK icon
821
Rockwell Automation
ROK
$51.4B
$3.63M 0.01%
24,120
-300
-1% -$50K
ELAN icon
822
Elanco Animal Health
ELAN
$12.4B
$3.59M 0.01%
113,902
+13,902
+14% +$455K
BPL
823
DELISTED
Buckeye Partners, L.P.
BPL
$3.57M 0.01%
123,024
+7,224
+6% +$230K
KPTI icon
824
Karyopharm Therapeutics
KPTI
$168M
$3.56M 0.01%
25,353
+2,806
+12% +$473K
FL
825
DELISTED
Foot Locker
FL
$3.55M 0.01%
66,680
+2,080
+3% +$104K

Similar funds

Macquarie Group's Q4 2018 Portfolio in Review

As of Q4 2018, Macquarie Group held 2,464 positions worth $51.8B, down 16% from $61.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Macquarie Group's Q4 2018 filing shows 302 new, 769 increased, 979 reduced and 219 closed positions. Its largest new stake was Rapid7: 873,643 shares worth $27.2M. The largest sale was Express Scripts Holding Company, an estimated $792M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Financials and Technology.

  • Macquarie Group's largest Q4 2018 buy was Rapid7: 873,643 shares worth $27.2M.
  • Macquarie Group added most to Cigna in Q4 2018, an estimated $723M increase.
  • Macquarie Group's biggest Q4 2018 reduction was Visa, cutting an estimated $129M.
  • Macquarie Group fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $792M.
  • Macquarie Group's ten largest holdings make up 16% of its $51.8B portfolio in Q4 2018.
  • Macquarie Group opened 302 new positions and closed 219 in Q4 2018.
  • Macquarie Group's portfolio value fell 16% quarter-over-quarter to $51.8B.

Based on Macquarie Group's 13F filing for Q4 2018, filed 15 Feb 2019.